INVITRO ACTIVITY OF HR-810, A NEW BROAD-SPECTRUM CEPHALOSPORIN

[1] SUSCEPTIBILITY OF GRAM-POSITIVE AEROBIC COCCI TO THE NEW CEPHALOSPORIN HR-810 [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 354 - 355

[2] RELATION BETWEEN BETA-LACTAMASE PRODUCTION AND ANTI-MICROBIAL ACTIVITY - COMPARISON OF THE NEW COMPOUND HR-810 WITH CEFOTAXIME [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 350 - 352

[3] Kayser F, 1982, Eur J Clin Microbiol, V1, P361, DOI 10.1007/BF02019935

[4] MOXALACTAM THERAPY OF INFECTIONS CAUSED BY CEPHALOTHIN-RESISTANT BACTERIA - INFLUENCE OF SERUM INHIBITORY ACTIVITY ON CLINICAL-RESPONSE AND ACQUISITION OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (03) : 351 - 355

[5] EMERGENCE OF RESISTANCE TO BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS DURING MOXALACTAM THERAPY OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) : 1037 - 1041

[6] CHROMOSOMAL BETA-LACTAMASES OF ENTEROBACTER-CLOACAE ARE RESPONSIBLE FOR RESISTANCE TO 3RD-GENERATION CEPHALOSPORINS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (06) : 918 - 925

[7] HR-810, A CEPHALOSPORIN WITH LOW AFFINITY FOR ENTEROBACTER-CLOACAE BETA-LACTAMASE [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 352 - 354

[8] 1980, STANDARD METHOD DILU

[1] SUSCEPTIBILITY OF GRAM-POSITIVE AEROBIC COCCI TO THE NEW CEPHALOSPORIN HR-810 [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 354 - 355

[2] RELATION BETWEEN BETA-LACTAMASE PRODUCTION AND ANTI-MICROBIAL ACTIVITY - COMPARISON OF THE NEW COMPOUND HR-810 WITH CEFOTAXIME [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 350 - 352

[3] Kayser F, 1982, Eur J Clin Microbiol, V1, P361, DOI 10.1007/BF02019935

[4] MOXALACTAM THERAPY OF INFECTIONS CAUSED BY CEPHALOTHIN-RESISTANT BACTERIA - INFLUENCE OF SERUM INHIBITORY ACTIVITY ON CLINICAL-RESPONSE AND ACQUISITION OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (03) : 351 - 355

[5] EMERGENCE OF RESISTANCE TO BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS DURING MOXALACTAM THERAPY OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) : 1037 - 1041

[6] CHROMOSOMAL BETA-LACTAMASES OF ENTEROBACTER-CLOACAE ARE RESPONSIBLE FOR RESISTANCE TO 3RD-GENERATION CEPHALOSPORINS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (06) : 918 - 925

[7] HR-810, A CEPHALOSPORIN WITH LOW AFFINITY FOR ENTEROBACTER-CLOACAE BETA-LACTAMASE [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) : 352 - 354

[8] 1980, STANDARD METHOD DILU